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Objective: To evaluate the effect of autologous platelet rich plasma (PRP) combined with microfractures
on the treatment of chondral defects. The hypothesis of the study was that PRP can enhance cartilage
repair after microfractures.
Methods: A chronic full-thickness chondral lesion of the medial femoral condyle was performed in 15
sheep. Animals were divided into three groups, according to treatment: group 1: microfractures; group
2: microfracturesþ PRP and ﬁbrin glue gel; group 3: microfracturesþ liquid-PRP injection. Animals were
sacriﬁced at 6 months after treatment. Macroscopic appearance was evaluated according to International
Cartilage Repair Society (ICRS) score; cartilage stiffness was analyzed with an electromechanical indenter
(Artscan 200); histological appearance was scored according to a modiﬁed O’Driscoll score. Comparison
between groups for each outcome was performed with KruskaleWallis test, and Tukey’s test for pairwise
comparisons.
Results: Macroscopic ICRS score of group 2 was signiﬁcantly better than those of the other groups, and
score of group 1 was signiﬁcantly lower than those of the other groups. Scores of group 1 and 3 were
signiﬁcantly lower than that of normal cartilage. Mean cartilage stiffness of groups 1 and 3 was signif-
icantly lower than that of normal cartilage. Histological total scores of group 2 and 3 were signiﬁcantly
better than that of group 1.
Conclusions: PRP showed a positive effect on cartilage repair and restoration after microfractures. The
procedure was more effective when PRP was used as a gel in comparison with liquid intra-articular
injection. Histological analysis revealed that none of experimental treatments produced hyaline cartilage.
 2010 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
Microfracture procedure is one of the most frequently used
techniques for the treatment for focal defects of articular cartilage.
Biological rationale of microfractures is based on stimulation of
bone-marrow stem cells (BMSCs) tomigrate to the site of injury and
differentiate in a chondrogenic cell line. However, several clinical
and animal studies showed that repaired tissue obtained after
microfractures is ﬁbrocartilage, containing a high quantity of type I
collagen1e6. This could be due to an insufﬁcient local stimulation
necessary to modulate chondrogenic differentiation of BMSCs7.iuseppe Milano, Department
elli 8, 00168 Rome, Italy.
Milano).
Elsevier Ltd on behalf of OsteoartIt is well known that some platelet-derived growth factors (GFs)
can stimulate chondrogenic differentiation of BMSCs and enhance
chondrocyte proliferation and metabolism8e17.
Platelet rich plasma (PRP) is deﬁned as a volume of the plasma
fraction of autologous blood having a platelet concentration above
baseline18; consequently, it contains a high concentration of
platelet-derived GFs with a potential promotive effect on tissue
healing and regeneration19. Recent in-vitro studies showed that PRP
stimulates in-vitro chondrocyte proliferation and extra-cellular
matrix (ECM) biosynthesis and enhances proliferation and chon-
drogenic differentiation of BMSCs20e24. However, no previous
studies tested the in-vivo efﬁcacy of PRP in enhancing reparative
response of chondral defects induced by marrow stimulating
techniques, such as microfractures.
The purpose of the present study was to evaluate the effect of
PRP combined with microfractures on healing of focal chondral
defects of the knee. The primary objective of the study was tohritis Research Society International.
Fig. 1. Macroscopic appearance of an 8-mm full-thickness chondral defect on the
weight-bearing area of the medial femoral condyle 12 months after surgery. A mild
reparative response from surrounding cartilage can be observed along the margins of
the defect.
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and combined with PRP. The secondary objective was to compare
efﬁcacy of PRP used as gel or liquid intra-articular injection. The
hypotheses of the study were that PRP can enhance reparative
response of chondral defects after microfractures, and that efﬁcacy
of PRP is greater when used as gel placed over the lesion than liquid
intra-articular injection. The null hypotheses of the study were that
there are no signiﬁcant differences on chondral defect healing after
microfractures isolated or combinedwith PRP, and that there are no
signiﬁcant differences between gel and liquid PRP.
Materials and methods
For the present study, we used 15 sheep (sarda ewes at dry-off)
that came from the same extensive farming system. Age ranged
from 32 to 42 months (average: 38 months) and weight ranged
from 35 kg to 42 kg (average: 40 kg). Exclusion criteria for enrol-
ment of animals were: skeletal immaturity and degenerative
changes of the stiﬂe joint. Skeletal maturity was conﬁrmed by stiﬂe
radiographs to ensure the closure of the growth plates of the distal
femur and proximal tibia (physeal scar but no open physis).
Degenerative changes were assessed on radiographic exams, and
intraoperative macroscopic appearance of the articular cartilage.
All the animals underwent a veterinary examination to evaluate
general health status. Research protocol was approved by Ethic
Committee for Animal Experimentation of the University of Sassari,
where treatments were performed.
Surgical treatment
Surgery was performed using sterile conditions and under
general anaesthesia. On each animal, we performed a medial par-
apatellar arthrotomy on the right stiﬂe. A full-thickness articular
cartilage lesion on the weight-bearing area of the medial femoral
condyle was performed using an 8-mm harvester instrument for
osteochondral transplantation (OATS System; Arthrex, Naples, FL).
As the tip of the core harvester was sharp, difference between inner
and outer diameter of the instrument was negligible, so that the
exact diameter of the lesion was 8 mm. Noncalciﬁed cartilage was
removed from the defect using a hand curette, taking care of
retaining calciﬁed cartilage in the base of the defect. Accurate
haemostasis and surgical wound closure were then performed,
respecting anatomical layers. After surgery, the animals have been
left free in their fencings without any immobilization of the oper-
ated limb. Full weight-bearing was allowed as tolerated. No speciﬁc
exercise regimen was adopted.
A second surgery on the operated stiﬂe was performed after 12
months on each animal. After a medial parapatellar incision, the
lesion performed during the previous surgery was identiﬁed. As
a mild reparative response from surrounding cartilage was
observed along the borders of the lesion (Fig. 1), the margins of the
defect were debrided to restore the original diameter (8 mm), that
was checked with an appropriate 8-mm sizer/tamp from OATS
instrumentation set. The margins and the base of the lesion were
debrided using a small curette. Care was taken to remove the
calciﬁed layer of the cartilage leaving intact the subchondral plate,
and four perforations were then performed using a 1.5-mm K-wire
that was hammered into the subchondral bone. The depth of holes
penetrationwas standardized by marking the K-wire at 5 mm from
its tip.
Animals were assigned to three groups (ﬁve animals for each
group), according to the repair technique. In group 1, isolated
microfractures were performed. In group 2, a PRP and ﬁbrin glue
(Tissucol; Baxter BioSurgery, Baxter International Inc., Deerﬁeld, IL)
gel was placed over the lesion where microfractures werepreviously performed. Gel perfectly matched the size of the defect
and was sealed along the borders with ﬁbrin glue. In group 3, after
microfractures, 5 ml of liquid PRP was injected into the joint after
closing the surgical wound.PRP preparation
PRP was prepared by harvesting 60 ml of autologous blood from
each animal before the induction of anaesthesia. Blood was
centrifuged at 2400 rpm for 3 min. The precipitate was separated
and supernatant was centrifuged at 3000 rpm for 12 min. The
precipitate was collected and the ﬁnal product was 6e8 ml of liquid
PRP, which was used for intra-articular injection in group 3. PRP gel
was prepared by adding 2 ml of a Ca-gluconate solution (1 g/10 ml)
and 2 ml of ﬁbrin glue, consisting of a combination of ﬁbrinogen
and thrombin, to 6 ml of liquid PRP.
In a previous pilot study, centrifugation procedure of sheep
blood was optimized in order to obtain the greatest platelet
concentration18. Based on this study, we chose the setting with the
best PRP quantity/platelet concentration ratio. To conﬁrm this
result, on ﬁve animals, 1 week before surgery, 60 ml of autologous
blood were harvested for PRP preparation, according to the previ-
ously described method, and platelet count analysis was per-
formed. A 5 ml whole blood sample was then harvested from the
same animals and platelet count analysis was performed and
compared to those showed by PRP samples. Each samplewas tested
using a digital haematology analyzer (Advia 120 Hematology
Analyzer; GMI Inc., Ramsey, MN) and mean platelet concentration
(standard deviation (SD)) was assessed in PRP and whole blood. A
non-parametric test (ManneWhitney U-test) was used to compare
mean platelet concentration between PRP and whole blood. Data
analysis showed a fourfold greater platelet concentration in PRP
(1415164103/ml) than inwhole blood (35164103/ml) with
a highly signiﬁcant difference between them (P< 0.0001).
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Five animals were randomly assigned to each group after ﬁrst
treatment. Randomization was performed using a random number
generator and assigning the ﬁrst ﬁve numbers of the random list to
the animals of group 1, the following ﬁve numbers to those of group
2, and the last ﬁve numbers to group 3. The randomization list was
then put in increasing order from 1 to 15 and kept by an inde-
pendent researcher, and the assignment code of each animal was
revealed to the surgeon only at the time of the second surgery.
Post-operative treatment
After second surgery, the animals have been left free in their
fencings without any immobilization of the operated limb. Full
weight-bearing was allowed as tolerated. No speciﬁc exercise
regimen was adopted. General health and weight-bearing status
were monitored during recovery by a veterinary.
Outcome measurements
Animals were euthanized by intravenous injection of 1 ml/kg
pentobarbital sodium 6 months after treatment (second surgery).
Distal femurs of the operated and contralateral limb were har-
vested after removing all peri-articular soft tissues.
On each operated sample, a macroscopic evaluation of the
treated defect was performed to evaluate repaired tissue. Moreover,
a biomechanical test and a histological evaluation were performed.
Histological assessment was considered the primary outcome of
the study.
Macroscopic evaluation of cartilage repair was assessed using
the International Cartilage Repair Society (ICRS) evaluation
score25,26 (Table I).
Biomechanical evaluation was performed by measurement of
articular cartilage stiffness using the Artscan 200 (Artscan Oy,
Helsinki, Finland). The Artscan 200 is an electromechanical
indentation probe which consists of a measurement rod
(length¼ 150 mm and diameter¼ 5 mm) attached to a handle. TheTable I
ICRS macroscopic evaluation of cartilage repair
Categories Score
Degree of defect repair
In level with surrounding cartilage 4
75% repair of defect depth 3
50% repair of defect depth 2
25% repair of defect depth 1
0% repair of defect depth 0
Integration to border zone
Complete integration with surrounding cartilage 4
Demarcating border <1 mm 3
3/4 of graft integrated, 1/4 with a notable border >1 mm width 2
1/2 of graft integrated with surrounding cartilage, 1/2 with
a notable border >1 mm
1
From no contact to 1/4 of graft integrated with surrounding
cartilage
0
Macroscopic appearance
Intact smooth surface 4
Fibrillated surface 3
Small, scattered ﬁssures or cracs 2
Several, small or few but large ﬁssures 1
Total degeneration of grafted area 0
Overall repair assessment
Grade I: normal 12
Grade II: nearly normal 11e8
Grade III: abnormal 7e4
Grade IV: severely abnormal 3e1distal end of the rod consists of an inclined reference plate and
a protruding cylindrical indenter (height¼ 0.3 mm and diame-
ter¼ 1.0 mm). When the reference plate is pressed against cartilage
surface, the indenter induces a constant deformation on the carti-
lage. The force by which the cartilage resists the deformation is
detected as indenter force (N). Consistent measurements were
taken by applying manually a constant 10 N force to the cartilage
surface to be tested for 1 s intervals over 60 s under Artscan 200
software’s control, and recording the mean indenter force, which is
a measure of stiffness. An average of three mean stiffness values
was taken and calculated. Each testing series was performed on the
central part of the defect, and approximately on the same area of
the medial femoral condyle of the contralateral healthy stiﬂe.
After biomechanical evaluation, each operated sample was ﬁxed
in 10% buffered neutral formalin for 7 days, decalciﬁed in ethylene
diamine tetra-acetate (EDTA) buffered saline (pH 7.4) (0.25 mol/l),
dehydrated by serial ethanol washing and embedded in parafﬁn
wax. Samples were cut under visual control at three levels. Five
sagittal cuts (6 mm thick) from the central third of the defect were
obtained, using a motorized microtome. Slices were stained with
haematoxylineeosin (HeE) and Safranin-O/fast green, and exam-
ined under the light microscope.
Each slice was evaluated by three different authors and scored
according to a modiﬁed version of the grading system developed by
O’Driscoll et al.27,28 (Table II). On each sample, the mean score from
observation of all histological sections was obtained from the three
observers, and the mean of the three mean observations was then
calculated.
Investigators that assessed outcomes were well-experienced in
managing outcome measurement tools and were blind to
treatment.
Data analysis
Data were analyzed using statistical software SPSS 10.1 (SPSS
Inc.). Outcome variables were: macroscopic evaluation score,
cartilage stiffness, and histological score. Each variable was
expressed as mean value (SD) for each group. Comparison
between groups for each outcome was performed with the Krus-
kaleWallis test. A post-hoc analysis was then performed with the
Tukey’s test for multiple pairwise comparisons. 95% conﬁdence
intervals (CI) of estimated differences between means were calcu-
lated for each comparison. Signiﬁcance was set at P< 0.05.
A post-hoc power analysis was based on the primary outcome
(histological score), and according to the primary hypothesis of the
study.
Results
Macroscopic evaluation
Macroscopic evaluation showed that in group 1 (micro-
fractures), repaired tissue partially covered the defect. Healing
tissue was much thinner than normal surrounding cartilage and
was more evident in the areas over and surrounding the
microfractures. In some areas, subchondral bone was still exposed
[Fig. 2(A)].
In group 2 (microfracturesþ PRP gel), the defect area was
completely covered by repair tissue which showed a good inte-
grationwith healthy surrounding cartilage. Repaired tissue showed
similar thickness, appearance and colour to that of normal cartilage.
Macroscopic evaluation did not show ﬁbrillation and/or ﬁssuration
of the repaired tissue [Fig. 2(B)].
In group 3 (microfracturesþ liquid PRP), repaired tissue covered
almost completely the defect. Microfractures holes were not
Table II
Modiﬁed O’Driscoll histological score
Variable Comment Score
Tissue Morphology (Ti) Mostly hyaline cartilage 4
Mostly ﬁbrocartilage 3
Mostly non-cartilage 2
Exclusively non-cartilage 1
Matrix staining (Matx) None 1
Slight 2
Moderate 3
Strong 4
Structural integrity (Stru) Severe disintegration 1
Cysts or disruption 2
No organization of chondrocytes 3
Beginning of columnar organization
of chondrocytes
4
Normal, similar to healthy
mature cartilage
5
Chondrocyte clustering
in implant (Clus)
25e100% of the cells clustered 1
<25% of the cells clustered 2
No clusters 3
Intactness of the calciﬁed layer,
formation of tidemark (Tide)
<25% of the calciﬁed layer intact 1
25e49% of the calciﬁed layer intact 2
50e75% of the calciﬁed layer intact 3
76e90% of the calciﬁed layer intact 4
Complete intactness of the calciﬁed
cartilage layer
5
Subchondral bone
formation (Bform)
No formation 1
Slight 2
Strong 3
Histological appraisal of
surface architecture (SurfH)
Severe ﬁbrillation of disruption 1
Moderate ﬁbrillation or irregularity 2
Slight ﬁbrillation or irregularity 3
Normal 4
Histological appraisal
defect ﬁlling (FilH)
<25% 1
26e50% 2
51e75% 3
76e90% 4
91e110% 5
Lateral integration of
implanted material (Latl)
Not bonded 1
Bonded at one hand/partially
both ends
2
Bonded at both sides 3
Basal integration of
implanted material (Basl)
<50% 1
50e70% 2
70e90% 3
91e100% 4
Inﬂammation (InfH) No inﬂammation 1
Slight inﬂammation 3
Strong inﬂammation 5
Maximum total score 45
Fig. 2. Macroscopic appearance of three samples from experimental groups: A. Group 1 (m
more evident in the areas over and surrounding the microfractures; B. Group 2 (microfractu
to that of normal cartilage, and a good integration with healthy surrounding cartilage; C. Gro
but is thin, poorly regular and consistent, especially in the inner part of the defect.
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in the central aspect of the defect. A good integration with the
healthy surrounding cartilage was evident [Fig. 2(C)].
Macroscopic scoring analysis revealed a signiﬁcant difference
between groups (P¼ 0.0001). Post-hoc analysis showed that ICRS
score of group 2 was signiﬁcantly greater than those of the other
groups, and score of group 1 was signiﬁcantly lower than those of
the other groups. ICRS scores of group 1 and 3 were signiﬁcantly
lower than that of normal cartilage (Table III).
Biomechanical evaluation
Biomechanical evaluation showed a signiﬁcant difference
between groups (P¼ 0.007). Post-hoc analysis showed that mean
stiffness of group 2 was greater than those of the other two groups,
although differences between the three groups were not signiﬁ-
cant. Only mean cartilage stiffness of group 2 approximated that of
controls. On the contrary, groups 1 and 3 showed a signiﬁcantly
lower mean stiffness than normal cartilage (Table IV).
Histological evaluation
Histological evaluation showed that in group 1, repair tissue
consisted of a thin layer of non-cartilaginous tissue. In some areas,
where microfractures holes had been performed, we found a great
amount of rounded cells resembling chondrocytes embedded in
a ﬁbrous and poorly organized ECM. In those areas, we observed an
intense Safranin-O staining. Tidemark was almost completely
absent in all the area of the defect. Healthy cartilage surrounding
the defect showed signs of suffering with a poor Safranin-O stain-
ing, an intense cell proliferation and clusters of chondrocyte-like
cells in the transitional and radial zones (Fig. 3).
In group 2, repair tissue covered almost completely the defect.
Its thickness was similar to that of healthy surrounding cartilage,
and contained a great amount of small rounded cells. Tissue
showed an intense Safranin-O staining of ECM, and a partial inte-
gration with the surrounding healthy cartilage in the radial zone,
although a clear transition between them was evident in the
transitional and superﬁcial zones. Moreover, we observed that
surrounding cartilage ﬂowed over the defect. In many areas, we
observed numerous clusters of chondrocyte-like cells in the tran-
sitional and radial zones and some clefts that deepened to the
radial zone. In these areas, Safranin-O staining was poor. Tidemark
was observed in some zones, but it did not appear completely
restored. Healthy surrounding cartilage showed an intense cell
proliferation with formation of cell clusters (Fig. 4).
In group 3, we observed a thin layer of repair tissue that covered
almost completely the defect, although it was thinner than normalicrofractures): healing tissue is much thinner than normal surrounding cartilage and
resþ PRP gel): repaired tissue (arrows) shows similar thickness, appearance and colour
up 3 (microfracturesþ liquid PRP): repaired tissue covers almost completely the defect,
Table III
Results of macroscopic evaluation
ICRS score (Mean SD) Differences
between means
P value 95% CI
Group 1 (N¼ 5) Group 2 (N¼ 5) Group 3 (N¼ 5) Group 4 (controls) (N¼ 15) Groups Value Lower limit Upper limit
3.6  1.34 11  1 5.8  1.09 12 1e2 7.4* 0.000 9.2095 5.5905
1e3 2.2* 0.015 4.0095 0.3905
1e4 8.4* 0.000 10.2095 6.5905
2e3 5.2* 0.000 3.3905 7.0095
2e4 1.0 0.416 2.8095 0.8095
3e4 6.2* 0.000 8.0095 4.3905
* Difference between means is statistically signiﬁcant for P< 0.05.
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tissue. Tissue showed a good Safranin-O staining, a great amount of
chondrocyte-like cells well-organized in columns, and rare clusters
in the in the transitional and radial zone. However, in some areas
we found a ﬁbrocartilaginous tissue with poor Safranin-O staining.
Tidemark was almost completely absent in the defect. Normal
surrounding cartilage showed an intense cell proliferation with
cluster formation (Fig. 5).
Histological scoring assessment showed a signiﬁcant difference
between groups for the following variables: matrix staining (Matx)
(P¼ 0.001), structural integrity (Stru) (P¼ 0.001), surface archi-
tecture (SurfH) (P¼ 0.006), defect ﬁlling (FillH) (P¼ 0.0001), basal
integration (Basl) (P¼ 0.0001) and total score (P¼ 0.0001). Post-hoc
analysis revealed that PRP groups (group 2 and 3) had a signiﬁ-
cantly greater mean score than that of microfracture group (group
1) for all the above mentioned variables. For FillH and Basl vari-
ables, mean scores of group 2 were also signiﬁcantly greater than
those of group 3 (Table V).Power analysis
Post-hoc power analysis based on the primary outcome (histo-
logical score) showed an effect size of 1.98 and a power (1 b) of
0.78.Discussion
Although treatment algorithm for chondral injuries is not well-
deﬁned, microfracture technique can be actually considered as
a ﬁrst-line option and is frequently used as standard treatment
against which other cartilage repair or reconstruction procedures,
such as autologous osteochondral graft or chondrocyte implanta-
tion, are compared3,5,29e32.
A recent systematic literature review on clinical efﬁcacy of
microfractures showed a high consensus between studies for the
rate of clinical improvement, while high variability was observed
for repair cartilage ﬁll grade32. Although almost all reviewed
studies reported a short-term clinical improvement, longer follow-Table IV
Results of biomechanical evaluation
Stiffness (indenter force: N) (Mean SD)
Group 1 (N¼ 5) Group 2 (N¼ 5) Group 3 (N¼ 5) Group 4 (controls) (N
2.92 0.81 4.98 1.54 3.60 0.85 5.81 1.44
* Difference between means is statistically signiﬁcant for P< 0.05.up showed consistent functional decline and increased failure
rate32.
Several experimental in-vitro studies have demonstrated that
BMSCs have a high chondrogenic differentiation potential33e36, and
that cells originating from subchondral plate are similar to human
adult mesenchymal stem cells derived from bone-marrow aspi-
rates17. However, in-vivo studies showed that BMSCs, both sus-
pended or implanted over scaffolds, repaired cartilage defects by
formation of ﬁbrocartilaginous tissue37e43. Similarly, histological
studies on human biopsies or animal models conﬁrmed that
microfracture procedure cannot restore normal hyaline cartilage,
but usually leads to the formation of ﬁbrocartilage or hybrid
repaired tissue with a variable amount of type II collagen1e6. For
this reason, many researchers made efforts to improve mechanical
and biochemical quality of repaired tissue obtained after
microfractures.
Some authors showed that biologic or synthetic biocompatible
scaffolds could improve chondrogenic differentiation of BMSCs
derived from microfractures44e48. In-vitro studies showed that
chondrogenesis can be also stimulated by some GFs, such as TGF-
beta superfamily8,9,13,16,17, BMP 2, 4, 6, and 712,14,15, and FGF 2 and
1810,11; other authors combined the use of scaffolds and GFs to
improve cartilage repair after microfractures49e53.
Potential efﬁcacy of PRP to repair chondral defects was initially
supposed for its high content in chondrogenic GFs54. Gaissmaier
et al.20 showed that addition of human platelet supernatant to
monolayer cultures of chondrocytes induced cell proliferation but
de-differentiation towards a ﬁbroblast-like phenotype. Subse-
quently, Akeda et al.21, in an experimental study on porcine model,
showed that chondrocytes cultured in a medium containing 10% of
autologous PRP underwent a small but signiﬁcant increase in
proliferation and anabolic activity. Furthermore, recent in-vitro
studies showed that PRP increase proliferation and chondrogenic
differentiation of BMSCs22,24. Drengk et al.23, in an experimental
model similar to that used in the present study, showed that PRP
had a primary effect on cultured chondrocytes, that maintained
stable phenotype; however it revealed a smaller but consistent
promotive effect on proliferation and chondrogenic differentiation
of BMSCs. According to these in-vitro studies, PRP could effectivelyDifferences between
means
P value 95% CI
¼ 15) Groups Value Lower limit Upper limit
1e2 2.06 0.068 4.2429 0.1229
1e3 0.674 0.813 2.8569 1.5089
1e4 2.89* 0.008 5.0729 0.7071
2e3 1.386 0.302 0.7969 3.5689
2e4 0.83 0.702 3.0129 1.3529
3e4 2.216* 0.046 4.3989 0.0331
Fig. 3. Histological sections of group 1 (microfractures): A. Repaired tissue (arrows) was much thinner than normal cartilage (asterisk) (HeE staining. Original magniﬁcation 12.5);
B. In some areas, corresponding to microfracture holes, a great amount of rounded cells were embedded in a ﬁbrous and poorly organized ECM. In those areas, some spots of intense
Safranin-O staining could be seen (asterisk). (Safranin-O staining. Original magniﬁcation 40); C. Repaired tissue (left) was partially integrated with the surrounding healthy
cartilage (asterisk), which showed signs of suffering with a poor Safranin-O staining, and cluster formation (Safranin-O staining. Original magniﬁcation 100).
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chondrogenic effect of PRP was performed in an extra-articular
environment55 Authors implanted a PRP gel used as carrier for
cultured autologous chondrocytes in the subcutaneous tissue of
rabbits and observed cartilage formation into the PRP scaffold55.
The primary hypothesis of the present study was that intra-
articular use of PRP aftermicrofractures can improve formation rate
and quality of repaired tissue in comparison with microfracture
procedure alone. The use of PRP to improve the outcome of
microfractures has several potential advantages. First, PRP prepa-
ration is simple, rapid and not expensive, and can represent a valid
therapeutic option to employ, as indicated, without any thorough
preoperative planning. Further, it can be used as one-stage treat-
ment as does not necessitate cultured cells, but acts on cells drawn
into the defect from microfractures. Finally, it does not need any
supplementary scaffold that, besides costs, implies a potential risk
of inﬂammatory reaction, and a more complex surgical technique
that is not always suitable for an all-arthroscopic procedure.
Nevertheless, subchondral perforations we performed, partially
differed from standard microfracture procedure described by
Steadman56. First, we used a 1.5-mm K-wire instead of dedicated
arthroscopic awls, as, in our opinion, the tip of the commercially
available awls was too large to perform multiple perforations in an
about 0.5-cm2 lesion. In fact, using a 1.5-mm K-wire, and leaving
a distance of at least 1 mm between each hole and the margins of
the defect, microfractures were separated by a 3-mm bone bridge,
according to suggestions by Steadman56. Second, as subchondral
bone of the distal medial condyle of sheep stiﬂe is thinner than that
of human knee57, extending perforations to 5 mm in depthFig. 4. Histologic sections of group 2 (microfracturesþ PRP gel): A. Thickness of repaired tis
lateral integration with the surrounding cartilage in the radial layer, although a clear transi
(Safranin-O staining. Original magniﬁcation 100); B. Repaired tissue showed a great amou
could be observed in some areas. (Safranin-O staining. Original magniﬁcation 200); C. Num
clefts that deepened to the radial zone, with a poor Safranin-O staining were observed in sprobably caused a deep penetration beyond the subchondral plate
and into the marrow cavity, which can affect reparative response58.
Results of the present study showed that, compared with iso-
lated microfracture procedure, adjunctive use of PRP produced
repair tissue that was more mechanically competent and histo-
logically differentiated. Moreover, on comparing two different PRP
preparations, we observed that solid gel applied over the chondral
defect was more effective than liquid solution injected into the
joint, determining better mechanical and histological results,
although without a signiﬁcant difference, except for defect ﬁlling
and basal integration of repair tissue.
The use of ﬁbrin glue was previously reported as carrier for
chondrocytes and BMSCs40,59e61. In-vitro studies showed that
chondrocytes seeded in ﬁbrin glue produced high-quality
cartilage59e61; however, Shao et al.40 in an in-vivo study in rabbits,
observed that BMSCs seeded in ﬁbrin glue matrix leaded to
formation of a poor-quality cartilage-like tissue. In the present
study, we did not use ﬁbrin glue as scaffold for cell seeding, but it
was mixed to PRP to enhance adhesive capacity and consistence of
gel, and reduce the risk of PRP dispersal into the joint. However, we
did not test separately the effect of PRP gel and ﬁbrin glue
combinedwithmicrofractures, so that we cannot establishwhether
the improvement observed was caused by PRP or ﬁbrin glue, or the
combination thereof.
We did not observe macroscopic signs of inﬂammation within
the joint, nor histological ﬁndings of cell reaction typical of immune
response in the repair tissue associated with the use of xenogenic
ﬁbrin glue, as reported in other studies with different animal
models28.sue (right) was similar to that of healthy surrounding cartilage (asterisk) with a partial
tion between the two zones was still evident in the transitional and superﬁcial layers.
nt of small rounded cells and an intense Safranin-O staining of ECM. A calciﬁed layer
erous clusters of chondrocyte-like cells in the transitional and radial zones and some
ome areas. (Safranin-O staining. Original magniﬁcation 100).
Fig. 5. Histologic sections of group 3 (microfracturesþ liquid PRP): A. A thin layer of repaired tissue (arrows) covered almost completely the defect, with a clear demarcation respect
to healthy tissue (asterisk) (HeE staining. Original magniﬁcation 12.5); B. A great amount of chondrocyte-like cells well-organized in columns, and rare clusters in the transitional
and radial zone could be seen. ECM showed a good Safranin-O staining. (Safranin-O staining. Original magniﬁcation 100); C. In some areas, a ﬁbrocartilaginous tissue with poor
Safranin-O staining could be observed (arrow head). Normal surrounding cartilage (asterisk) showed an intense cell proliferation with cluster formation. (Safranin-O staining.
Original magniﬁcation 40).
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obtained in the PRP-gel group was not signiﬁcantly different from
normal cartilage and stiffer than that observed in the other
experimental groups, histological analysis revealed that none ofTable V
Results of histological evaluation (15 observations per sample)
Variables Mean score SD
Group 1 (N¼ 5) Group 2 (N¼ 5) Group 3 (N¼ 5)
TI 2.3 0.67 2.8 0.71 2.4 0.90
MATX 1.6 0.84 2.9 0.90 2.5 0.69
STRU 1.6 0.51 2.7 0.62 2.8 0.95
CLUS 1.1 0.31 1.2 0.45 1.2 0.45
TIDE 1.5 0.84 2 0.95 1.5 0.77
BFORM 2 0.66 2.1 0.83 1.6 0.88
SURFH 1.1 0.31 1.9 0.9 1.8 0.56
FILH 1.6 0.51 4 0.85 2.6 0.76
LATL 1.2 0.42 1.5 0.51 1.7 0.87
BASL 1.6 0.51 3.2 0.62 2.4 0.90
INFH 1.8 1.03 1.1 0.57 1.6 0.95
Total 17.4 3.23 25.8 5.07 22.6 4.64
* Difference between means is statistically signiﬁcant for P< 0.05.experimental treatments produced hyaline cartilage. Repaired
tissue observed in the PRP-gel group was better than that observed
in the liquid-PRP group; however, there was a great amount of cell
clusters and small but deep clefts, and lateral integration withDifferences between
means
P value 95% CI
Groups Value Lower limit Upper limit
1e2 0.5333 0.278 1.3701 0.3034
1e3 0.1211 0.921 0.8845 0.6424
2e3 0.4123 0.353 0.3083 1.1329
1e2 1.3167* 0.001 2.1475 0.4859
1e3 0.9263* 0.014 1.6844 0.1683
2e3 0.3904 0.387 0.3251 1.1058
1e2 1.1500* 0.004 1.9655 0.3345
1e3 1.2421* 0.001 1.9862 0.4980
2e3 0.0921 0.945 0.7944 0.6102
1e2 0.1500 0.689 0.5928 0.2928
1e3 0.1632 0.591 0.5672 0.2409
2e3 0.0132 0.996 0.3945 0.3682
1e2 0.5000 0.362 1.3841 0.3841
1e3 0.0263 0.997 0.8330 0.7803
2e3 0.4737 0.294 0.2877 1.2350
1e2 0.1667 0.885 1.0266 0.6933
1e3 0.3158 0.593 0.4689 1.1005
2e3 0.4825 0.263 0.2581 1.2230
1e2 0.8167* 0.014 1.4859 0.1475
1e3 0.7947* 0.008 1.4053 0.1841
2e3 0.0219 0.995 0.5544 0.5982
1e2 2.4000* 0.000 3.1730 1.6270
1e3 1.0316* 0.003 1.7369 0.3263
2e3 1.3684* 0.000 0.7028 2.0341
1e2 0.3833 0.407 1.1060 0.3394
1e3 0.5368 0.130 1.1963 0.1226
2e3 0.1535 0.820 0.7759 0.4689
1e2 1.6500* 0.000 2.4334 0.8666
1e3 0.8737* 0.014 1.5885 0.1589
2e3 0.7763* 0.021 0.1017 1.4510
1e2 0.6333 0.228 0.2897 1.5563
1e3 0.1684 0.878 0.6737 1.0106
2e3 0.4649 0.338 1.2598 0.3299
1e2 8.4333* 0.000 13.1232 3.7434
1e3 5.2316* 0.014 9.5108 0.9524
2e3 3.2018 0.143 0.8371 7.2406
G. Milano et al. / Osteoarthritis and Cartilage 18 (2010) 971e980978surrounding cartilage reported at macroscopic evaluation was not
conﬁrmed at histology. These ﬁndings can represent negative
prognostic factors for long-term survival. Furthermore, presence of
poorly stained areas at Safranin-O staining was indicative of
limited metabolic cell activity and poor-quality extra-cellular
matrix. Reparative response observed in the liquid-PRP group was
better than that observed in the microfracture group at the
histological evaluation; however, differences between the two
groups were not signiﬁcant at mechanical evaluation. It would be
interesting to investigate if prolonged treatment with liquid PRP,
by repeating intra-articular injections during ﬁrst period after
surgery, can improve the effects of platelet-derived GFs on repar-
ative process.
One of the limits of PRP preparation is that method is not
standardized. Several studies on the use of PRP for connective
tissue repair reported discrepancies in centrifugation setting,
quantity of blood harvested, and quantity of PRP obtained; more-
over, a wide variability of GF concentration was observed62e64. We
did not analyze GF content of PRP, but performed a preliminary
study to optimize centrifugation setting that provided platelet
concentration approximating fourfold that of entire blood. This
concentration has been suggested as optimal for best efﬁcacy of
PRP65; however, it is still unclear if effects of PRP on cell prolifer-
ation and differentiation are dose-dependent, and related to
platelet or GF concentration.
In the present study, we realized an experimental model of
chronic isolated chondral defect, without joint instability. Although
at the time of reparative treatment we refreshed the lesion, as
usually performed during arthroscopic microfracture procedure,
we supposed that chronic model would resemble intra-articular
environment usually observed in clinical practice during treatment
of this type of lesions. However, we did not quantiﬁed markers of
cartilage degradation and inﬂammatory response associated to
chronic chondral damage, and we do not know if reparative
response can be inﬂuenced by timing of lesion.
We recognized some other shortcomings of the study. First,
we did not perform a histological evaluation at time zero (before
second surgery) to evaluate reparative response to induced full-
thickness chondral injury. In fact, hand curettage of articular
cartilage frequently removes the calciﬁed cartilage layer, thus
promoting tissue repair; moreover, it is difﬁcult to distinguish
macroscopically between noncalciﬁed and calciﬁed cartilage, and
we did use any validated method, as suggested by Frisbie et al.66,
to assess retention or removal of calciﬁed cartilage during ﬁrst
surgery. However, macroscopic appearance of the defects at 12
months after ﬁrst surgery did not show a consistent basal repair.
Second, follow-up was too short to evaluate the outcome of
a treatment that has shown a consistent deterioration over
time32. Third, we did not provide a direct proof of the chon-
drogenic effect of PRP, as the purpose of the study was limited to
the evaluation of reparative response after microfractures with
and without PRP. Finally, we did not verify retention of PRP gel
into the defect; therefore, we do not know if an eventual loos-
ening of PRP gel played a role in limiting the efﬁcacy of this
treatment.
In conclusion, the use of PRP combined with microfractures for
the treatment of chronic full-thickness focal chondral defects of
femoral condyle produced, at 6 months, a repair tissue showing
better macroscopic, mechanical, and histological results than those
observed after isolated microfractures. PRP gel was more effective
than liquid injectable PRP. However, none of the experimental
treatments produced hyaline cartilage.
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